Table 2.
Data set | IBC versus Non-IBC | p53 mutation versus normal | PIK3 mutation versus normal | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Receptor status | ER-negative | ER-positive | ER-negative | ER-positive | ER-negative | ER-positive | ||||||
Phenotype | IBC | Non-IBC | IBC | Non-IBC | mutation | normal | mutation | normal | mutation | normal | mutation | normal |
Pts # | 19 vs 27 | 6 vs 31 | 44 vs 11 | 14 vs 31 | 8 vs 49 | 15 vs 57 | ||||||
Feature # | 10 | 100 | 10 | 100 | 10 | 100 | 10 | 100 | 10 | 100 | 10 | 100 |
FDR q value | 1.000 | 1.000 | 0.280 | 0.500 | 0.14 | 0.33 | 0.49 | 0.6 | 0.08 | 0.09 | 0.24 | 0.55 |
Fold difference * | ||||||||||||
< 0.5 | 0 | 20 | 0 | 2 | 1 | 9 | 2 | 29 | 0 | 0 | 0 | 17 |
≥0.5 - < 1.0 | 4 | 55 | 1 | 41 | 1 | 37 | 5 | 47 | 1 | 23 | 6 | 50 |
≥1.0 - < 1.2 | 2 | 11 | 1 | 10 | 1 | 11 | 1 | 11 | 3 | 18 | 1 | 17 |
≥1.2 - < 1.5 | 3 | 12 | 4 | 18 | 2 | 15 | 1 | 9 | 4 | 21 | 2 | 10 |
≥1.5 - < 2.0 | 0 | 0 | 2 | 20 | 2 | 22 | 1 | 4 | 1 | 23 | 0 | 5 |
≥2.0 - < 3.0 | 0 | 1 | 2 | 9 | 3 | 6 | 0 | 0 | 1 | 14 | 1 | 1 |
≥3.0 - < 4.0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
≥4.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Data set | WANG | TRANSBIG | Mainz | |||||||||
Receptor status | ER-negative | ER-positive | ER-negative | ER-positive | ER-negative | ER-positive | ||||||
Recurrence | Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | Yes | No |
Pts # | 29 vs 50 | 29 vs 50 | 18 vs 45 | 23 vs 112 | 11 vs 20 | 30 vs 139 | ||||||
Feature # | 10 | 100 | 10 | 100 | 10 | 100 | 10 | 100 | 10 | 100 | 10 | 100 |
FDR q value | 0.2 | 0.26 | 0.004 | 0.02 | 0.820 | 0.91 | 0.010 | 0.03 | 0.47 | 0.58 | 0.01 | 0.03 |
Fold difference * | ||||||||||||
< 0.5 | 2 | 35 | 3 | 68 | 2 | 26 | 1 | 26 | 1 | 13 | 3 | 59 |
≥0.5 - < 1.0 | 6 | 51 | 7 | 30 | 4 | 47 | 5 | 52 | 5 | 44 | 5 | 26 |
≥1.0 - < 1.2 | 0 | 7 | 0 | 2 | 3 | 21 | 2 | 12 | 0 | 5 | 1 | 3 |
≥1.2 - < 1.5 | 0 | 5 | 0 | 0 | 1 | 6 | 1 | 8 | 1 | 16 | 0 | 0 |
≥1.5 - < 2.0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 17 | 1 | 2 |
≥2.0 - < 3.0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
≥3.0 - < 4.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 |
≥4.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
*Log2 Difference = abs(mean log2 intensity for group1 - mean log2 intensity for group 2) where "abs" is absolute value.
The numbers of probe sets with a given level of differential expression are shown for the 6 comparisons. Analyses were performed separately for Estrogen Receptor (ER)-positive and ER-negative cancers. IBC = inflammatory breast cancer, PI3K = Phosphatidylinositol-3 kinase, FDR = false discovery rate. The WANG, TRANSBIG, Mainz data sets correspond to references 2, 3 and 28. Probe sets with mean log2 transformed expression difference >1 between comparisons groups are highlighted in bold.